The study specifically looked at patients who were considering hip and knee replacements. When researchers provided decision aids to patients — in this instance, joint disorder aids included recommendations to lose weight, increase physical activity and take medications for treating osteoarthritis — there were 26 percent fewer hip replacement surgeries and 38 percent fewer knee replacement surgeries.
Costs were also lowered by up to 21 percent over six months. According to a Kaiser Health News report, patients with hip osteoarthritis who used decision aids had a total treatment cost of $13,489 — an 18.5 percent decrease from the control group, which had a cost of $16,557.
More Articles on Hospital Costs:
California Bill Would Require Insurers to Slash Chemotherapy Pill Costs
Many Hospitals Aren’t Notified of Incoming Stroke Patients Despite Benefits
Hippocratic Oath vs. Cost Consciousness: The Great Debate for Physicians
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
